Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-17T09:59:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-25T18:05:46.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:19:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Padova, Italy was added to the locations list and Padua, Italy was removed.
    Difference
    0.0%
    Check dated 2026-04-04T05:48:30.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Napoli, Italy was replaced with Naples, Italy and the Naples site was added to the study locations. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T20:07:33.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This appears to be an internal version update not affecting study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-03-06T18:01:45.000Z thumbnail image

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.